JP2016514462A5 - - Google Patents

Info

Publication number

JP2016514462A5

JP2016514462A5 JP2016503288A JP2016503288A JP2016514462A5 JP 2016514462 A5 JP2016514462 A5 JP 2016514462A5 JP 2016503288 A JP2016503288 A JP 2016503288A JP 2016503288 A JP2016503288 A JP 2016503288A JP 2016514462 A5 JP2016514462 A5 JP 2016514462A5

Authority

JP

Japan

Prior art keywords

seq

acid sequence

amino acid

nucleic acid

cell

Prior art date

2014-03-15

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 125000003275 alpha amino acid group Chemical group 0.000 claims 102
• 150000007523 nucleic acids Chemical class 0.000 claims 55
• 108010019670 Chimeric Antigen Receptors Proteins 0.000 claims 52
• 108010047041 Complementarity Determining Regions Proteins 0.000 claims 35
• 210000004027 cell Anatomy 0.000 claims 34
• 108020004707 nucleic acids Proteins 0.000 claims 34
• 102000039446 nucleic acids Human genes 0.000 claims 34
• 238000012986 modification Methods 0.000 claims 24
• 230000004048 modification Effects 0.000 claims 24
• 108091028043 Nucleic acid sequence Proteins 0.000 claims 21
• 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 claims 16
• 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 claims 16
• 230000004068 intracellular signaling Effects 0.000 claims 14
• 239000013598 vector Substances 0.000 claims 14
• 201000010099 disease Diseases 0.000 claims 11
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 11
• 239000003795 chemical substances by application Substances 0.000 claims 9
• 230000011664 signaling Effects 0.000 claims 9
• 206010028980 Neoplasm Diseases 0.000 claims 8
• 230000000139 costimulatory effect Effects 0.000 claims 8
• 229920001184 polypeptide Polymers 0.000 claims 8
• 102000004196 processed proteins & peptides Human genes 0.000 claims 8
• 108090000765 processed proteins & peptides Proteins 0.000 claims 8
• 108091032973 (ribonucleotides)n+m Proteins 0.000 claims 7
• 102100034922 T-cell surface glycoprotein CD8 alpha chain Human genes 0.000 claims 7
• 201000003793 Myelodysplastic syndrome Diseases 0.000 claims 6
• 201000011510 cancer Diseases 0.000 claims 6
• 239000003814 drug Substances 0.000 claims 5
• 238000000338 in vitro Methods 0.000 claims 5
• 238000000034 method Methods 0.000 claims 5
• 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 claims 4
• 208000010833 Chronic myeloid leukaemia Diseases 0.000 claims 4
• 206010058314 Dysplasia Diseases 0.000 claims 4
• 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 claims 4
• 102100025390 Integrin beta-2 Human genes 0.000 claims 4
• 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 claims 4
• 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 claims 4
• 210000001744 T-lymphocyte Anatomy 0.000 claims 4
• 102100022153 Tumor necrosis factor receptor superfamily member 4 Human genes 0.000 claims 4
• 230000037396 body weight Effects 0.000 claims 4
• 201000003444 follicular lymphoma Diseases 0.000 claims 4
• 230000002489 hematologic effect Effects 0.000 claims 4
• 230000002401 inhibitory effect Effects 0.000 claims 4
• 238000004519 manufacturing process Methods 0.000 claims 4
• 210000005134 plasmacytoid dendritic cell Anatomy 0.000 claims 4
• 102000004169 proteins and genes Human genes 0.000 claims 4
• 108090000623 proteins and genes Proteins 0.000 claims 4
• 102100026882 Alpha-synuclein Human genes 0.000 claims 3
• 102100029822 B- and T-lymphocyte attenuator Human genes 0.000 claims 3
• 108010074708 B7-H1 Antigen Proteins 0.000 claims 3
• 102100024263 CD160 antigen Human genes 0.000 claims 3
• 102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 claims 3
• 102100034458 Hepatitis A virus cellular receptor 2 Human genes 0.000 claims 3
• 101000834898 Homo sapiens Alpha-synuclein Proteins 0.000 claims 3
• 101000864344 Homo sapiens B- and T-lymphocyte attenuator Proteins 0.000 claims 3
• 101000761938 Homo sapiens CD160 antigen Proteins 0.000 claims 3
• 101000889276 Homo sapiens Cytotoxic T-lymphocyte protein 4 Proteins 0.000 claims 3
• 101001068133 Homo sapiens Hepatitis A virus cellular receptor 2 Proteins 0.000 claims 3
• 101001138062 Homo sapiens Leukocyte-associated immunoglobulin-like receptor 1 Proteins 0.000 claims 3
• 101001137987 Homo sapiens Lymphocyte activation gene 3 protein Proteins 0.000 claims 3
• 101000611936 Homo sapiens Programmed cell death protein 1 Proteins 0.000 claims 3
• 101000652359 Homo sapiens Spermatogenesis-associated protein 2 Proteins 0.000 claims 3
• 101000831007 Homo sapiens T-cell immunoreceptor with Ig and ITIM domains Proteins 0.000 claims 3
• 101000666896 Homo sapiens V-type immunoglobulin domain-containing suppressor of T-cell activation Proteins 0.000 claims 3
• 102000017578 LAG3 Human genes 0.000 claims 3
• 102100020943 Leukocyte-associated immunoglobulin-like receptor 1 Human genes 0.000 claims 3
• 102100024216 Programmed cell death 1 ligand 1 Human genes 0.000 claims 3
• 102100024834 T-cell immunoreceptor with Ig and ITIM domains Human genes 0.000 claims 3
• 102100038282 V-type immunoglobulin domain-containing suppressor of T-cell activation Human genes 0.000 claims 3
• 150000001413 amino acids Chemical class 0.000 claims 3
• 230000000694 effects Effects 0.000 claims 3
• IJJVMEJXYNJXOJ-UHFFFAOYSA-N fluquinconazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1N1C(=O)C2=CC(F)=CC=C2N=C1N1C=NC=N1 IJJVMEJXYNJXOJ-UHFFFAOYSA-N 0.000 claims 3
• 239000003112 inhibitor Substances 0.000 claims 3
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 2
• 208000024893 Acute lymphoblastic leukemia Diseases 0.000 claims 2
• 208000036170 B-Cell Marginal Zone Lymphoma Diseases 0.000 claims 2
• 208000025324 B-cell acute lymphoblastic leukemia Diseases 0.000 claims 2
• 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 claims 2
• 102100038080 B-cell receptor CD22 Human genes 0.000 claims 2
• 208000011691 Burkitt lymphomas Diseases 0.000 claims 2
• 102100027207 CD27 antigen Human genes 0.000 claims 2
• 102000017420 CD3 protein, epsilon/gamma/delta subunit Human genes 0.000 claims 2
• 108050005493 CD3 protein, epsilon/gamma/delta subunit Proteins 0.000 claims 2
• -1 CD86 Proteins 0.000 claims 2
• 102100037904 CD9 antigen Human genes 0.000 claims 2
• 206010061850 Extranodal marginal zone B-cell lymphoma (MALT type) Diseases 0.000 claims 2
• 102100026122 High affinity immunoglobulin gamma Fc receptor I Human genes 0.000 claims 2
• 101000884305 Homo sapiens B-cell receptor CD22 Proteins 0.000 claims 2
• 101000914511 Homo sapiens CD27 antigen Proteins 0.000 claims 2
• 101000738354 Homo sapiens CD9 antigen Proteins 0.000 claims 2
• 101000913074 Homo sapiens High affinity immunoglobulin gamma Fc receptor I Proteins 0.000 claims 2
• 101000935040 Homo sapiens Integrin beta-2 Proteins 0.000 claims 2
• 101000777628 Homo sapiens Leukocyte antigen CD37 Proteins 0.000 claims 2
• 101000917858 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-A Proteins 0.000 claims 2
• 101000917839 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-B Proteins 0.000 claims 2
• 101000934338 Homo sapiens Myeloid cell surface antigen CD33 Proteins 0.000 claims 2
• 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 claims 2
• 101000934346 Homo sapiens T-cell surface antigen CD2 Proteins 0.000 claims 2
• 101000716102 Homo sapiens T-cell surface glycoprotein CD4 Proteins 0.000 claims 2
• 101000934341 Homo sapiens T-cell surface glycoprotein CD5 Proteins 0.000 claims 2
• 101000946843 Homo sapiens T-cell surface glycoprotein CD8 alpha chain Proteins 0.000 claims 2
• 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 claims 2
• 108010021625 Immunoglobulin Fragments Proteins 0.000 claims 2
• 102000008394 Immunoglobulin Fragments Human genes 0.000 claims 2
• 108010064593 Intercellular Adhesion Molecule-1 Proteins 0.000 claims 2
• 102100037877 Intercellular adhesion molecule 1 Human genes 0.000 claims 2
• 208000031671 Large B-Cell Diffuse Lymphoma Diseases 0.000 claims 2
• 102100031586 Leukocyte antigen CD37 Human genes 0.000 claims 2
• 102100029185 Low affinity immunoglobulin gamma Fc region receptor III-B Human genes 0.000 claims 2
• 108010064548 Lymphocyte Function-Associated Antigen-1 Proteins 0.000 claims 2
• 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 claims 2
• 206010025323 Lymphomas Diseases 0.000 claims 2
• 201000003791 MALT lymphoma Diseases 0.000 claims 2
• 208000025205 Mantle-Cell Lymphoma Diseases 0.000 claims 2
• 208000034578 Multiple myelomas Diseases 0.000 claims 2
• 102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 claims 2
• 208000015914 Non-Hodgkin lymphomas Diseases 0.000 claims 2
• 206010035226 Plasma cell myeloma Diseases 0.000 claims 2
• 208000006994 Precancerous Conditions Diseases 0.000 claims 2
• 208000007541 Preleukemia Diseases 0.000 claims 2
• 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 claims 2
• 108091008874 T cell receptors Proteins 0.000 claims 2
• 102000016266 T-Cell Antigen Receptors Human genes 0.000 claims 2
• 208000029052 T-cell acute lymphoblastic leukemia Diseases 0.000 claims 2
• 102100025237 T-cell surface antigen CD2 Human genes 0.000 claims 2
• 102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 claims 2
• 102100025244 T-cell surface glycoprotein CD5 Human genes 0.000 claims 2
• 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 claims 2
• 101710165473 Tumor necrosis factor receptor superfamily member 4 Proteins 0.000 claims 2
• 208000033559 Waldenström macroglobulinemia Diseases 0.000 claims 2
• 230000001154 acute effect Effects 0.000 claims 2
• OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 claims 2
• 208000035269 cancer or benign tumor Diseases 0.000 claims 2
• 208000024207 chronic leukemia Diseases 0.000 claims 2
• 206010012818 diffuse large B-cell lymphoma Diseases 0.000 claims 2
• 201000009277 hairy cell leukemia Diseases 0.000 claims 2
• 201000005787 hematologic cancer Diseases 0.000 claims 2
• 208000024200 hematopoietic and lymphoid system neoplasm Diseases 0.000 claims 2
• 230000031146 intracellular signal transduction Effects 0.000 claims 2
• 230000001589 lymphoproliferative effect Effects 0.000 claims 2
• 230000003211 malignant effect Effects 0.000 claims 2
• 201000007924 marginal zone B-cell lymphoma Diseases 0.000 claims 2
• 208000021937 marginal zone lymphoma Diseases 0.000 claims 2
• 230000002062 proliferating effect Effects 0.000 claims 2
• 210000000278 spinal cord Anatomy 0.000 claims 2
• 208000024891 symptom Diseases 0.000 claims 2
• 108020005345 3' Untranslated Regions Proteins 0.000 claims 1
• 208000032568 B-cell prolymphocytic leukaemia Diseases 0.000 claims 1
• 239000002126 C01EB10 - Adenosine Substances 0.000 claims 1
• 108020004414 DNA Proteins 0.000 claims 1
• 101000801234 Homo sapiens Tumor necrosis factor receptor superfamily member 18 Proteins 0.000 claims 1
• 229940124790 IL-6 inhibitor Drugs 0.000 claims 1
• 108091036407 Polyadenylation Proteins 0.000 claims 1
• 208000035416 Prolymphocytic B-Cell Leukemia Diseases 0.000 claims 1
• 102100033728 Tumor necrosis factor receptor superfamily member 18 Human genes 0.000 claims 1
• 229960005305 adenosine Drugs 0.000 claims 1
• 239000000556 agonist Substances 0.000 claims 1
• 230000001413 cellular effect Effects 0.000 claims 1
• 230000003750 conditioning effect Effects 0.000 claims 1
• 229940079593 drug Drugs 0.000 claims 1
• 229940124302 mTOR inhibitor Drugs 0.000 claims 1
• 239000003628 mammalian target of rapamycin inhibitor Substances 0.000 claims 1
• 239000013600 plasmid vector Substances 0.000 claims 1
• 230000001177 retroviral effect Effects 0.000 claims 1
• 230000000638 stimulation Effects 0.000 claims 1
• 238000002560 therapeutic procedure Methods 0.000 claims 1
• 229960003989 tocilizumab Drugs 0.000 claims 1
• 238000013518 transcription Methods 0.000 claims 1
• 230000035897 transcription Effects 0.000 claims 1
• 230000002463 transducing effect Effects 0.000 claims 1
• 238000002054 transplantation Methods 0.000 claims 1
• 239000013603 viral vector Substances 0.000 claims 1